Pyrrolo pyrimidines as agents for the inhibition of cystein...

Details Pyrrolo pyrimidines as agents for the inhibition of cystein... Pyrrolo pyrimidines as agents for the inhibition of cystein...

2002-08-29

2008-11-18

Coleman, Brenda L. (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S252160, C514S265100, C514S263100, C514S263200, C514S263220, C544S359000, C544S280000, C544S230000, C544S231000, C544S264000, C544S276000

Reexamination Certificate

active

07452886

ABSTRACT:
The invention provides compounds of Formula I or a pharmaceutically acceptable salt or ester thereof wherein the symbols have meaning as defined, which are inhibitors of cathepsin K and find use pharmaceutically for treatment of diseases and medical conditions in which cathepsin K is implicated, e.g. various disorders including inflammation, rheumatoid arthritis, osteoarthritis, osteoporosis and tumors.

REFERENCES:
patent: 4220770 (1980-09-01), Gass
patent: 5683999 (1997-11-01), Jadhav et al.
patent: 437 911 (1967-11-01), None
Wang et. al.; International Journal fo Pharmaceutics; 2004; 277; 73-79.
Caplus Abstract Accession No. 2001:816647 & WO 01/83460.
Caplus Abstract Accession No. 1999:710017 & Heterocycles vol. 51, No. 11, (1999), Yong-Goo Chang and Kyongtae Kim, “A Facile Synthesis of N-arylcyanoformamidoximes . . . ”, pp. 2653-2666.
Caplus Abstract Accession No. 1999:504266 & Bioorg. Med Chem Lett. vol. 9, No. 14, 1999, G Caravatti et al, “Structure-Based Design of a Non-Peptidic Antagonist . . . ”, pp. 1973-1978.
Caplus Abstract Accession No. 1996:628861 & Bioorg. Med. Chem. Lett. vol. 6, No. 19, 1996, T Besson et al., Antimicrobial Evaluation of 3,1-Benzoxazin-4-ones . . . pp. 2342-2348.
Caplus Abstract Accession No. 1990:515257 Nippon Kagaku Kaishi vol. 4, 1990, Y Mori et al, Syntheses and Reactions of Cyano-1,3,5-Triazines, pp. 396-4000.
Falgeuyret, J.P. et al, “Novel, Nonpetidic Cyanamides as Potent and Reversible Inhibitors of Human Cathepsins K and L”, 2001, Journal of Medicinal Chemistry, vol. 44, pp. 94-104.

Affiliated with

Also associated with

Rating

Pyrrolo pyrimidines as agents for the inhibition of cystein... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrrolo pyrimidines as agents for the inhibition of cystein..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrolo pyrimidines as agents for the inhibition of cystein... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4036591